We explored this possibility using ammonium trichloro (dioxoethylene-0,0′) tellurate (AS101), an immunomodulator first synthesized at Bar-Ilan University (Ramat-Gan, Israel) that increases expression of wild-type p53 in B16-F10 melanoma cells [45]. This evidence concerns the gene TP53 and melanoma.